{"entity":{"type":"insider","cik":"0001776881","url":"/insider/0001776881","json_url":"/insider/0001776881.json","name":"Keen Nicholas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":13,"first":"2021-03-16","last":"2024-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Keen Nicholas","source":"filing","n_filings":13,"first_seen":"2021-03-16","last_seen":"2024-07-08"}],"transactions":[{"id":2070112,"accession":"0001415889-24-019385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019385","line_url":"/filing/0001415889-24-019385#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":779.0,"shares_display":"779","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":15299.56,"total_display":"15,299.56","total_whole":"15,300","shares_owned_after":62024.0,"shares_owned_after_display":"62,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-08","scope":"insider"},{"id":3262180,"accession":"0001415889-24-010414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010414","line_url":"/filing/0001415889-24-010414#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF SCIENTIFIC OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":790.0,"shares_display":"790","price_per_share":23.81,"price_display":"23.81","price_state":"stated","total_value":18809.9,"total_display":"18,809.90","total_whole":"18,810","shares_owned_after":62803.0,"shares_owned_after_display":"62,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":2793187,"accession":"0001209191-24-000888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000888","line_url":"/filing/0001209191-24-000888#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2640.0,"shares_display":"2,640","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":46200.0,"total_display":"46,200.00","total_whole":"46,200","shares_owned_after":63593.0,"shares_owned_after_display":"63,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":8704662,"accession":"0001209191-23-052253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052253","line_url":"/filing/0001209191-23-052253#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5440.0,"total_display":"5,440.00","total_whole":"5,440","shares_owned_after":38233.0,"shares_owned_after_display":"38,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":8254454,"accession":"0001209191-23-041570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041570","line_url":"/filing/0001209191-23-041570#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":336.0,"shares_display":"336","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":8433.6,"total_display":"8,433.60","total_whole":"8,434","shares_owned_after":38505.0,"shares_owned_after_display":"38,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8575318,"accession":"0001209191-23-023352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023352","line_url":"/filing/0001209191-23-023352#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":319.0,"shares_display":"319","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":6734.09,"total_display":"6,734.09","total_whole":"6,734","shares_owned_after":38841.0,"shares_owned_after_display":"38,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8150780,"accession":"0001209191-23-002193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002193","line_url":"/filing/0001209191-23-002193#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1817.0,"shares_display":"1,817","price_per_share":29.06,"price_display":"29.06","price_state":"stated","total_value":52802.02,"total_display":"52,802.02","total_whole":"52,802","shares_owned_after":39160.0,"shares_owned_after_display":"39,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":5405914,"accession":"0001209191-21-059375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059375","line_url":"/filing/0001209191-21-059375#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2178.0,"shares_display":"2,178","price_per_share":45.1,"price_display":"45.10","price_state":"stated","total_value":98227.8,"total_display":"98,227.80","total_whole":"98,228","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-05","scope":"insider"},{"id":5405911,"accession":"0001209191-21-059375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059375","line_url":"/filing/0001209191-21-059375#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1188.0,"shares_display":"1,188","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":53460.0,"total_display":"53,460.00","total_whole":"53,460","shares_owned_after":2178.0,"shares_owned_after_display":"2,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":4287178,"accession":"0001209191-21-056655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-056655","line_url":"/filing/0001209191-21-056655#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1955.0,"shares_display":"1,955","price_per_share":45.01,"price_display":"45.01","price_state":"stated","total_value":87994.55,"total_display":"87,994.55","total_whole":"87,995","shares_owned_after":3366.0,"shares_owned_after_display":"3,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-17","scope":"insider"},{"id":4287176,"accession":"0001209191-21-056655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-056655","line_url":"/filing/0001209191-21-056655#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":135000.0,"total_display":"135,000.00","total_whole":"135,000","shares_owned_after":5321.0,"shares_owned_after_display":"5,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4427429,"accession":"0001209191-21-054789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054789","line_url":"/filing/0001209191-21-054789#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":8321.0,"shares_owned_after_display":"8,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":4141400,"accession":"0001209191-21-046997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046997","line_url":"/filing/0001209191-21-046997#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":18321.0,"shares_owned_after_display":"18,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-16","scope":"insider"},{"id":4138852,"accession":"0001209191-21-024641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-024641","line_url":"/filing/0001209191-21-024641#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":28321.0,"shares_owned_after_display":"28,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":5146967,"accession":"0001209191-21-021150","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-021150","line_url":"/filing/0001209191-21-021150#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217.0,"shares_display":"217","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":6076.0,"total_display":"6,076.00","total_whole":"6,076","shares_owned_after":38321.0,"shares_owned_after_display":"38,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-16","scope":"insider"},{"id":5146961,"accession":"0001209191-21-021150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021150","line_url":"/filing/0001209191-21-021150","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776881","owner_name":"Keen Nicholas","owner_display_name":"Keen Nicholas","owner_url":"/insider/0001776881","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9783.0,"shares_display":"9,783","price_per_share":28.4950424205254,"price_display":"28.50","price_state":"stated","total_value":278767.0,"total_display":"278,767.00","total_whole":"278,767","shares_owned_after":38821.0,"shares_owned_after_display":"38,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS PLC","url":"/issuer/0001761612","role":"Officer (CHIEF SCIENTIFIC OFFICER)","n_filings":13,"first_seen":"2021-03-16","last_seen":"2024-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776881","retrieved_at":"2026-08-27T02:51:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}